Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) closed at $79.67 up 0.73% from its previous closing price of $79.09. In other words, the price has increased by $0.73 from its previous closing price. On the day, 1.95 million shares were traded. BMRN stock price reached its highest trading level at $79.81 during the session, while it also had its lowest trading level at $77.75.
Ratios:
For a deeper understanding of Biomarin Pharmaceutical Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 83.20. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 2.74. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on May 17, 2024, Downgraded its rating to Neutral and sets its target price to $72 from $104 previously.
On May 14, 2024, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $113.
On November 15, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $100.Wells Fargo initiated its Overweight rating on November 15, 2023, with a $100 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 30 ’24 when Mueller Brian sold 5,000 shares for $75.19 per share. The transaction valued at 375,950 led to the insider holds 72,159 shares of the business.
Davis George Eric sold 40,850 shares of BMRN for $3,043,802 on May 28 ’24. The EVP, Chief Legal Officer now owns 56,157 shares after completing the transaction at $74.51 per share. On May 10 ’24, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, sold 20,000 shares for $81.14 each. As a result, the insider received 1,622,800 and left with 474,994 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMRN now has a Market Capitalization of 15127739392 and an Enterprise Value of 15177679872. As of this moment, Biomarin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 74.56, and their Forward P/E ratio for the next fiscal year is 27.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.11 while its Price-to-Book (P/B) ratio in mrq is 2.98. Its current Enterprise Value per Revenue stands at 6.141 whereas that against EBITDA is 51.718.
Stock Price History:
Over the past 52 weeks, BMRN has reached a high of $99.56, while it has fallen to a 52-week low of $73.68. The 50-Day Moving Average of the stock is -4.61%, while the 200-Day Moving Average is calculated to be -9.30%.
Shares Statistics:
For the past three months, BMRN has traded an average of 1.75M shares per day and 2606700 over the past ten days. A total of 188.60M shares are outstanding, with a floating share count of 186.28M. Insiders hold about 1.90% of the company’s shares, while institutions hold 99.43% stake in the company. Shares short for BMRN as of 1715731200 were 3739356 with a Short Ratio of 2.13, compared to 1713139200 on 3688638. Therefore, it implies a Short% of Shares Outstanding of 3739356 and a Short% of Float of 1.9800000000000002.
